SEC Form 4 · accession 0001209191-16-106746
Horizon Pharma plc · HZNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Carey
Officer — EVP, Chief Business Officer
Period of report
Mar 5, 2015
Accepted (ET)
Mar 7, 2016 · 6:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Feb 19, 2016 | G | 24,406 | $0.00 | D | 0 | D | |
| Ordinary Shares | Feb 19, 2016 | G | 24,406 | $0.00 | A | 82,061 | I | By Robert F. Carey III Trust dated 4/24/2001 |
| Ordinary SharesF2 | Mar 5, 2016 | M | 31,025 | — | A | 31,025 | D | |
| Ordinary Shares | Mar 5, 2016 | F | 9,616 | $16.78 | D | 21,409 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF2,F3 | — | Mar 5, 2016 | M | 31,025 | D | — | — | Ordinary Shares | 31,025 | 62,050 | D |
Explanation of responses
- F1Includes 1,161 ordinary shares of the Issuer acquired by the reporting person on December 1, 2015 pursuant to an employee stock purchase program.
- F2Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
- F3On March 5, 2014, the reporting person was granted 124,100 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.